Assembly Biosciences, Inc.
ASMB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001426800
No open-market purchases or sales by Assembly Biosciences, Inc. insiders were filed in the last 90 days; 92 institutions reported holding it in 13F filings for Q2 2026, worth $514.8M in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Assembly Biosciences, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 30 | 35 | +5 |
| Shares | 1.03M | 3.19M | +2.16M (+210.2%) |
| Value | $15.5M | $50.3M | +$34.7M (+223.5%) |
New holders (10)
Institutions that held Assembly Biosciences, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Gilead Sciences, Inc. | 2,209,471 | $34.9M | 2.25% |
| Peapod Lane Capital LLC | 62,970 | $993.7K | 0.98% |
| B Group, Inc. | 50,651 | $799.3K | 0.49% |
| Monimus Capital Management, LP | 42,067 | $663.8K | 0.63% |
| Man Group plc | 19,567 | $308.8K | 0.00% |
| Palumbo Wealth Management LLC | 11,427 | $180.3K | 0.07% |
| Connor, Clark & Lunn Investment Management Ltd. | 10,813 | $170.6K | 0.00% |
| BNP Paribas Arbitrage, SA | 302 | $4.77K | 0.00% |
| Northwestern Mutual Wealth Management Co | 260 | $4.10K | 0.00% |
| SBI Securities Co., Ltd. | 67 | $1.06K | 0.00% |
Sold out (5)
Institutions that held Assembly Biosciences, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Acuitas Investments, LLC | 62,315 | $943.4K |
| Millennium Management LLC | 37,553 | $568.6K |
| Citadel Advisors LLC | 12,720 | $192.6K |
| Amundi | 7,934 | $114.4K |
| Lazard Asset Management LLC | 71 | $1.00K |